Form 4: Clover Health Executive Reports RSU Tax Withholding
Statement of Changes in Beneficial Ownership
Brady Priest, CEO of Clover Care Services, reported the withholding of 36,113 shares to satisfy tax obligations related to RSU vesting.
Summary
- Brady Priest, CEO of Clover Care Services at Clover Health Investments, Corp., had 36,113 shares of Class A Common Stock withheld.
- The transaction occurred on April 18, 2026, at a price of $2.19 per share.
- The withholding was mandatory to cover tax obligations resulting from the vesting of restricted stock units (RSUs).
- Following this transaction, the reporting person maintains a beneficial ownership of 2,138,261 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as it is a routine administrative tax withholding transaction rather than a market-driven trade.
Positives
- The transaction is a routine administrative action related to tax obligations rather than a discretionary sale of stock.
- The reporting person retains a significant equity stake of 2,138,261 shares in the company.
Negatives
- The transaction results in a minor reduction of the executive's direct share ownership.
Risks
- Continued reliance on RSU vesting schedules for executive compensation.
Future Outlook
The remaining RSUs are scheduled to vest in equal quarterly installments of 6.25%, with the final vesting occurring on July 18, 2026, contingent upon continued service.
Management Comments
- The transaction represents shares automatically withheld to cover tax obligations upon the vesting of time-based restricted stock units.
Industry Context
StockSavvy.ai notes that mandatory tax withholding transactions are standard industry practice for executives receiving equity-based compensation and do not typically signal a change in management sentiment regarding company performance.
Comparison to Industry Standards
- The use of automatic share withholding for tax obligations is a standard corporate governance practice among U.S. publicly traded companies.
- The reporting structure complies with SEC Section 16(a) requirements for timely disclosure of insider transactions.
Stakeholder Impact
- Minimal impact on shareholders as the transaction is a standard tax-related equity adjustment.
Next Steps
- Final vesting of remaining RSU tranches scheduled for July 18, 2026.
Key Dates
| Date | Description |
|---|---|
| 07/18/2022 | Original grant date of the restricted stock units. |
| 04/18/2026 | Vesting date of RSUs and date of tax withholding transaction. |
| 04/21/2026 | Date of filing for the Form 4. |
| 07/18/2026 | Final scheduled vesting date for the remaining RSUs. |
Keywords
Clover Health, CLOV, Form 4, Insider Trading, Equity Compensation, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.